Biobetters, Supergenerics Hold Many Advantages for Pharma Companies

This article was originally published at https://www.drugpatentwatch.com/blog/biobetters-supergenerics-hold-many-advantages-pharma-companies/

By Larry Ramer, DrugPatentWatch writer A growing number of pharmaceutical companies are looking to simultaneously benefit from the low costs of developing generic treatments and the increased market share and…

The post Biobetters, Supergenerics Hold Many Advantages for Pharma Companies appeared first on DrugPatentWatch.

Comments are closed.